• Corpus ID: 207868798

Conference on ‘ The future of animal products in the human diet : health and environmental concerns ’ Postgraduate Winner

  title={Conference on ‘ The future of animal products in the human diet : health and environmental concerns ’ Postgraduate Winner},
  author={Heidi M. Staudacher and Kevin Whelan},
Irritable bowel syndrome (IBS) is a functional bowel disorder characterised by abdominal pain or discomfort with disordered defecation. This review describes the role of the gastrointestinal (GI) microbiota in the pathogenesis of IBS and how dietary strategies to manage symptoms impact on the microbial community. Evidence suggests a dysbiosis of the luminal and mucosal colonic microbiota in IBS, frequently characterised by a reduction in species of Bifidobacteria which has been associated with… 

Tables from this paper


Mechanisms and efficacy of dietary FODMAP restriction in IBS
An emerging body of research now demonstrates the efficacy of fermentable carbohydrate restriction in IBS; however, limitations still exist with this approach owing to a limited number of randomized trials, in part due to the fundamental difficulty of placebo control in dietary trials.
Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis
The present meta-analysis supports the efficacy of a low FODMAP diet in the treatment of functional gastrointestinal symptoms and more studies looking at greater number of patients and long-term adherence need to be conducted.
Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome.
This randomized controlled trial demonstrated a reduction in concentration and proportion of luminal bifidobacteria after 4 wk of fermentable carbohydrate restriction, effective in managing IBS symptoms.
Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial.
A diet low in FODMAPs reduces IBS symptoms as well as traditional IBS dietary advice, and combining elements from these 2 strategies might further reduce symptoms of IBS.
A role for the gut microbiota in IBS
  • S. Collins
  • Medicine
    Nature Reviews Gastroenterology &Hepatology
  • 2014
The evidence implicating the gut microbiota in not only the expression of the intestinal manifestations of IBS, but also the psychiatric morbidity that coexists in up to 80% of patients with IBS is described.
Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.
B infantis 35624 alleviates symptoms in IBS; this symptomatic response was associated with normalization of the ratio of an anti-inflammatory to a proinflammatory cytokine, suggesting an immune-modulating role for this organism, in this disorder.
Do Interventions Which Reduce Colonic Bacterial Fermentation Improve Symptoms of Irritable Bowel Syndrome?
IBS may be associated with rapid excretion of gaseous products of fermentation, whose reduction may improve symptoms, and this work aimed to assess the relationship between IBS symptoms and fermentation rates in IBS.
Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects
The GFD led to reductions in beneficial gut bacteria populations and the ability of faecal samples to stimulate the host's immunity, and the GFD may constitute an environmental variable to be considered in treated CD patients for its possible effects on gut health.
Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects.
The present study suggests that instability of intestinal microbiota may be involved in IBS, however, further studies are needed to associate the instability with specific IBS symptoms or with specific bacterial groups and species.
Gut microbiota influences low fermentable substrate diet efficacy in children with irritable bowel syndrome
It is suggested that an LFSD may be effective in decreasing GI symptoms in children with IBS and microbial factors such as gut microbiome composition and stool metabolites while on the diet may relate to LFSD efficacy.